Johnson Financial Group Inc (Wisconsin)’s Ionis Pharmaceuticals IONS Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-670	Closed	-$43.8K	–	1014
2025 Q3	$43.8K	Buy	+670	New	+$32.7K	﹤0.01%	624
2018 Q1	–	Sell	-60	Closed	-$3K	–	583
2017 Q4	$3K	Buy	+60	New	+$3.29K	﹤0.01%	547
2015 Q4	–	Sell	-500	Closed	-$20K	–	802
2015 Q3	$20K	Hold	500	–	–	﹤0.01%	575
2015 Q2	$29K	Hold	500	–	–	0.01%	560
2015 Q1	$32K	Buy	+500	New	+$33.9K	0.01%	567

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s IONS Position: Q4 2025 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 670 shares — an estimated $43.8K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in IONS in Q1 2015 and held it in 5 quarters. The position peaked at $43.8K in Q3 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

Johnson Financial Group Inc (Wisconsin) reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 670 Ionis Pharmaceuticals shares in Q4 2025, an estimated $43.8K.
Johnson Financial Group Inc (Wisconsin) first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 5 quarters.
Johnson Financial Group Inc (Wisconsin)'s Ionis Pharmaceuticals position peaked at $43.8K in Q3 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q4 2025, filed 12 Feb 2026.